Table 2.
Variable | Fertile control | Patient before CoQ10 | Patient after CoQ10 | Patient before Centrum | Patient after Centrum |
---|---|---|---|---|---|
CoQ10 level (ng/mL) | 56.2±38.5 | 41.6±29.8d) | 76.9±26.3b),e) | 38.9±27.6d) | 40.2±28.1d),g) |
ROS (×104 RLU/min/20 million spermatozoa | 0.07±0.03 | 3.52±1.29e) | 2.68±1.31c),e) | 2.8±0.96e) | 2.08±1.04c),e),f) |
TAC (mmol/L) | 1.12±0.21 | 0.73±0.36d) | 0.92±0.4b),d) | 0.56±0.24d) | 0.73±0.3c),d),f) |
Catalase (U/mL) | 12.45±2.49 | 8.42±2.21e) | 9.8±2.06b),e) | 6.72±1.75e) | 7.8±1.4b),e),g) |
Sperm DNA fragmentation (%) | 13.2±3.8 | 35.2±6.4e) | 32.1±7.9a),e) | 28.3±5.1e) | 25.7±4.1b),e),g) |
CoQ10, coenzyme Q10; ROS, reactive oxygen species; TAC, total antioxidant capacity; FDR, false discovery rate.
vs. patients before CoQ10, FDR p<0.05;
vs. patients before CoQ10, FDR p<0.01;
vs. patients before CoQ10, FDR p<0.001;
vs. fertile control group, FDR p<0.01;
vs. fertile control group, FDR p<0.001;
vs. patients after CoQ10, FDR p<0.01;
vs. patients after CoQ10, FDR p<0.001.